©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 114045
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.114045
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.114045
Table 1 Patients’ baseline characteristics, n (%)/mean ± SD
| Variable | Patients’ characteristics |
| Gender | |
| Female | 57 (70.4) |
| Male | 24 (29.6) |
| Age (years) | 55 ± 15 |
| Cardiometabolic factors | |
| Arterial hypertension | 31 (38.3) |
| T2DM | 18 (22.2) |
| Dyslipidaemia | 32 (39.5) |
| Obesity | 26 (32.1) |
| Previous cardiovascular event | 4 (4.9) |
| Presence of other autoimmune disorders | 6 (7.4) |
| Positivity of autoantibodies | |
| ANA | 67 (82.7) |
| SMA | 10 (12.3) |
| Anti-LKM | 5 (6.3) |
| Anti-LC-1 | 6 (9.0) |
| Anti-SLA/LP | 13 (16.0) |
| Elevated IgG levels | 21 (29.6) |
| Histological findings | |
| Hepatic steatosis | 39 (48.1) |
| Lymphocyte infiltrate | 55 (67.9) |
| Interface hepatitis | 5 (6.2) |
| Emperipolesis | 0 (0.0) |
| Hepatocyte rosettes | 0 (0.0) |
| Histological criteria for AIH | |
| Typical | 5 (6.2) |
| Compatible | 38 (46.9) |
| Atypical | 38 (46.9) |
- Citation: Ferreira AI, Costa Azevedo M, Macedo Silva V, Xavier S, Magalhães J, Cotter J. Not always autoimmune hepatitis: Hepatic steatosis is associated with autoantibodies positivity in patients with hepatocellular dysfunction. World J Hepatol 2026; 18(1): 114045
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/114045.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.114045